Product Description & Research Overview
Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates the body’s natural release of growth hormone by activating ghrelin receptors within the pituitary gland. Unlike many earlier growth hormone secretagogues, Ipamorelin has demonstrated a high degree of receptor selectivity, allowing it to promote growth hormone release with minimal stimulation of cortisol, prolactin, or acetylcholine.
Its relatively short half-life of approximately two hours allows growth hormone to be released in natural, pulsatile patterns that more closely resemble normal physiology. Because of this selective mechanism, Ipamorelin has become one of the most extensively researched peptides for muscle development, recovery, body composition, sleep quality, and healthy aging.
Researchers continue to investigate Ipamorelin for its potential to increase lean muscle mass, enhance recovery following exercise, improve collagen production, support fat metabolism while preserving muscle tissue, and improve sleep quality. It is frequently studied alone or in combination with GHRH peptides such as CJC-1295 No DAC or Sermorelin to examine synergistic effects on natural growth hormone secretion.
Research suggests Ipamorelin supports natural growth hormone release through several complementary mechanisms:
Timing: Ipamorelin is commonly researched on an empty stomach to minimize insulin interference with growth hormone release. Morning (fasted), pre-workout, or approximately 30 minutes before bedtime are the most frequently studied administration times depending on research objectives.
Reconstitution (10 mg Vial)
Step 1
Add 3.0 mL diluent.
Creates a 3.33 mg/mL solution.
Step 2
Draw 9 units (approximately 0.09 mL) for a 300 mcg dose.
Note: The infographic rounds this to 10 units, but mathematically a 10 mg vial reconstituted with 3.0 mL yields a concentration of 3.33 mg/mL, so a 300 mcg dose is approximately 9 units. If you prefer a clean 10-unit draw, reconstituting with 3.33 mL of diluent would achieve exactly 3 mg/mL, making 10 units = 300 mcg.
Quick Reference
Frequency: Daily
Approximate dose: 300 mcg
Approximate vial duration: About 4 weeks (33 doses at 300 mcg from a 10 mg vial)
Stacking Considerations
Ipamorelin is frequently researched alongside:
Continued Benefits
Continued research may demonstrate improvements in lean muscle development, body composition, recovery capacity, connective tissue health, and sleep quality.
Disclaimer
For research use only. Not for human consumption.
The dosing information provided is intended solely for laboratory and research purposes and is not medical advice. Always consult qualified professionals regarding research protocols.
These statements have not been evaluated by Health Canada or the U.S. Food and Drug Administration (FDA).
Research suggests Ipamorelin supports natural growth hormone release through several complementary mechanisms:
Timing: Ipamorelin is commonly researched on an empty stomach to minimize insulin interference with growth hormone release. Morning (fasted), pre-workout, or approximately 30 minutes before bedtime are the most frequently studied administration times depending on research objectives.
Reconstitution (10 mg Vial)
Step 1
Add 3.0 mL diluent.
Creates a 3.33 mg/mL solution.
Step 2
Draw 9 units (approximately 0.09 mL) for a 300 mcg dose.
Note: The infographic rounds this to 10 units, but mathematically a 10 mg vial reconstituted with 3.0 mL yields a concentration of 3.33 mg/mL, so a 300 mcg dose is approximately 9 units. If you prefer a clean 10-unit draw, reconstituting with 3.33 mL of diluent would achieve exactly 3 mg/mL, making 10 units = 300 mcg.
Quick Reference
Frequency: Daily
Approximate dose: 300 mcg
Approximate vial duration: About 4 weeks (33 doses at 300 mcg from a 10 mg vial)
Stacking Considerations
Ipamorelin is frequently researched alongside:
Initial Response
Performance & Recovery
Continued Benefits
Initial Response
Performance & Recovery
Continued Benefits
Research suggests Ipamorelin supports natural growth hormone release through several complementary mechanisms:
Timing: Ipamorelin is commonly researched on an empty stomach to minimize insulin interference with growth hormone release. Morning (fasted), pre-workout, or approximately 30 minutes before bedtime are the most frequently studied administration times depending on research objectives.
Reconstitution (10 mg Vial)
Step 1
Add 3.0 mL diluent.
Creates a 3.33 mg/mL solution.
Step 2
Draw 9 units (approximately 0.09 mL) for a 300 mcg dose.
Note: The infographic rounds this to 10 units, but mathematically a 10 mg vial reconstituted with 3.0 mL yields a concentration of 3.33 mg/mL, so a 300 mcg dose is approximately 9 units. If you prefer a clean 10-unit draw, reconstituting with 3.33 mL of diluent would achieve exactly 3 mg/mL, making 10 units = 300 mcg.
Quick Reference
Frequency: Daily
Approximate dose: 300 mcg
Approximate vial duration: About 4 weeks (33 doses at 300 mcg from a 10 mg vial)
Stacking Considerations
Ipamorelin is frequently researched alongside:
Initial Response
Performance & Recovery
Continued Benefits
